148 related articles for article (PubMed ID: 37814227)
1. CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells.
Xie B; Zhao L; Zhang Z; Zhou C; Tian Y; Kang Y; Chen J; Wei H; Li L
BMC Cancer; 2023 Oct; 23(1):955. PubMed ID: 37814227
[TBL] [Abstract][Full Text] [Related]
2. miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1.
Li C; Wang Y; Wang H; Wang B; Wang Y; Li N; Qin Y; Wang Y
Anal Cell Pathol (Amst); 2021; 2021():7407086. PubMed ID: 34395181
[TBL] [Abstract][Full Text] [Related]
3. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1246 by Targeting AXIN2 and GSK-3β Overcomes Drug Resistance and Induces Apoptosis in Chemo-resistant Leukemia Cells.
Xie B; Li L; Zhang Z; Zhao L; Cheng J; Zhou C; Cheng J; Yan J; Chen J; Yi J; Wang B; Jin S; Wei H
J Cancer; 2021; 12(14):4196-4208. PubMed ID: 34093820
[No Abstract] [Full Text] [Related]
5. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
Wang JJ; Yu JP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176
[TBL] [Abstract][Full Text] [Related]
6. LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.
Yao Q; Zhang L; Wang Y; Liu J; Yang L; Wang Y
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33969374
[TBL] [Abstract][Full Text] [Related]
7. Exosomes of glioma cells deliver miR-148a to promote proliferation and metastasis of glioblastoma via targeting CADM1.
Cai Q; Zhu A; Gong L
Bull Cancer; 2018; 105(7-8):643-651. PubMed ID: 29921422
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W
J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma.
Sun Z; Meng C; Wang S; Zhou N; Guan M; Bai C; Lu S; Han Q; Zhao RC
BMC Cancer; 2014 Aug; 14():616. PubMed ID: 25159494
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1.
Yang Z; Wang R; Zhang T; Dong X
Int J Clin Exp Pathol; 2015; 8(8):8869-80. PubMed ID: 26464628
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis.
Sun Z; Zhao L; Wang S; Wang H
Ann Hepatol; 2022 Jan; 27 Suppl 1():100571. PubMed ID: 34718169
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line.
Cao YX; Wen F; Luo ZY; Long XX; Luo C; Liao P; Li JJ
J Cell Biochem; 2020 Oct; 121(10):4022-4033. PubMed ID: 31793054
[TBL] [Abstract][Full Text] [Related]
13. MiR-423-5p aggravates lung adenocarcinoma via targeting CADM1.
Huang Y; Feng G
Thorac Cancer; 2021 Jan; 12(2):210-217. PubMed ID: 33205911
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1.
Wang HL; Zhou R; Liu J; Chang Y; Liu S; Wang XB; Huang MF; Zhao Q
Sci Rep; 2017 Sep; 7(1):11467. PubMed ID: 28904340
[TBL] [Abstract][Full Text] [Related]
16. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
Ke S; Li RC; Lu J; Meng FK; Feng YK; Fang MH
Int J Hematol; 2017 Aug; 106(2):258-265. PubMed ID: 28409330
[TBL] [Abstract][Full Text] [Related]
18. Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia.
Fisser MC; Rommer A; Steinleitner K; Heller G; Herbst F; Wiese M; Glimm H; Sill H; Wieser R
Mol Carcinog; 2015 Dec; 54(12):1815-9. PubMed ID: 25491945
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑145 promotes the apoptosis of leukemic stem cells and enhances drug‑resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1.
Wuxiao Z; Wang H; Su Q; Zhou H; Hu M; Tao S; Xu L; Chen Y; Hao X
Int J Mol Med; 2020 Oct; 46(4):1289-1300. PubMed ID: 32945355
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑214 promotes the EMT process in melanoma by downregulating CADM1 expression.
Wang SJ; Li WW; Wen CJ; Diao YL; Zhao TL
Mol Med Rep; 2020 Nov; 22(5):3795-3803. PubMed ID: 33000202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
